(Reuters) – The U.S. National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by Moderna Inc and Pfizer Inc.
(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
